Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $530.28 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $108.42 | 8 | $0 (2019) |
| Amgen Inc. | $107.52 | 5 | $0 (2019) |
| ViiV Healthcare Company | $72.09 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $53.65 | 3 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $50.51 | 3 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $37.49 | 3 | $0 (2019) |
| Gilead Sciences, Inc. | $30.63 | 1 | $0 (2023) |
| EMD Serono, Inc. | $23.68 | 1 | $0 (2020) |
| Novo Nordisk Inc | $13.19 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $12.01 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $30.63 | 1 | Gilead Sciences, Inc. ($30.63) |
| 2022 | $34.71 | 1 | ViiV Healthcare Company ($34.71) |
| 2020 | $23.68 | 1 | EMD Serono, Inc. ($23.68) |
| 2019 | $56.31 | 4 | Lilly USA, LLC ($29.22) |
| 2018 | $130.82 | 9 | ViiV Healthcare Company ($37.38) |
| 2017 | $254.13 | 15 | Amgen Inc. ($80.29) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/14/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.63 | General |
| 04/13/2022 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: HIV | ||||||
| 01/13/2020 | EMD Serono, Inc. | Serostim (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Endocrinology | ||||||
| 11/21/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 08/28/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/05/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Neuroscience | ||||||
| 03/29/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Diabetes | ||||||
| 11/15/2018 | ViiV Healthcare Company | JULUCA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: HIV | ||||||
| 09/20/2018 | ViiV Healthcare Company | JULUCA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: HIV | ||||||
| 09/10/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: pseudobulbar affect PBA | ||||||
| 07/23/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Endocrinology | ||||||
| 07/05/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Diabetes | ||||||
| 06/04/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/12/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.34 | General |
| Category: Cardiovascular | ||||||
| 03/06/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/20/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 12/18/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $30.83 | General |
| Category: Cardiovascular | ||||||
| 12/12/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Diabetes | ||||||
| 11/02/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: Diabetes | ||||||
| 10/10/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/13/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Diabetes | ||||||
| 05/23/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: DIABETES | ||||||
| 04/26/2017 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $13.17 | General |
| 04/19/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/30/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 20 | 1,248 | 2,274 | $433,756 | $106,007 |
| 2020 | 20 | 1,342 | 2,109 | $381,505 | $88,019 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 159 | 519 | $127,573 | $44,610 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 125 | 125 | $41,864 | $15,678 | 37.4% |
| 99491 | Chronic care management services by qualified health care professional, 30 minutes or more per calendar month | Office | 2021 | 64 | 183 | $77,775 | $10,362 | 13.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 73 | 284 | $55,664 | $7,990 | 14.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 85 | 127 | $24,384 | $6,898 | 28.3% |
| 99487 | Complex chronic care management services, first 60 minutes clinical staff time per calendar month | Office | 2021 | 47 | 105 | $30,030 | $6,864 | 22.9% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2021 | 16 | 38 | $10,944 | $3,487 | 31.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 112 | 112 | $10,752 | $1,960 | 18.2% |
| 99489 | Complex chronic care management services, each additional 60 minutes clinical staff time per calendar month | Office | 2021 | 20 | 56 | $14,336 | $1,846 | 12.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 131 | 145 | $16,760 | $1,398 | 8.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 18 | 22 | $3,564 | $1,055 | 29.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 150 | 284 | $5,112 | $849.00 | 16.6% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 23 | 23 | $1,288 | $688.62 | 53.5% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 17 | 20 | $2,720 | $664.71 | 24.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 33 | 33 | $3,168 | $582.78 | 18.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 29 | 29 | $1,914 | $461.31 | 24.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 110 | 133 | $3,724 | $299.25 | 8.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 12 | 12 | $792.00 | $175.88 | 22.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 12 | 12 | $696.00 | $74.76 | 10.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 12 | 12 | $696.00 | $62.16 | 8.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 163 | 477 | $117,241 | $31,777 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 130 | 130 | $43,680 | $14,394 | 33.0% |
| 99491 | Chronic care management services by qualified health care professional, 30 minutes or more per calendar month | Office | 2020 | 58 | 130 | $55,250 | $8,460 | 15.3% |
| 99487 | Complex chronic care management services 60 minutes clinical staff time | Office | 2020 | 41 | 96 | $27,456 | $6,520 | 23.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 89 | 137 | $26,304 | $5,559 | 21.1% |
About Dr. Steven Dillon, M.D
Dr. Steven Dillon, M.D is a Specialist healthcare provider based in Lawrence, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407857675.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Dillon, M.D has received a total of $530.28 in payments from pharmaceutical and medical device companies, with $30.63 received in 2023. These payments were reported across 31 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($530.28).
As a Medicare-enrolled provider, Dillon has provided services to 2,590 Medicare beneficiaries, totaling 4,383 services with total Medicare billing of $194,026. Data is available for 2 years (2020–2021), covering 40 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Lawrence, KS
- Active Since 08/09/2005
- Last Updated 02/12/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1407857675
Products in Payments
- TRULICITY (Drug) $108.42
- Prolia (Biological) $79.23
- ELIQUIS (Drug) $53.65
- NUEDEXTA (Drug) $50.51
- PRADAXA (Drug) $37.49
- JULUCA (Drug) $37.38
- APRETUDE (Biological) $34.71
- Serostim (Drug) $23.68
- Aimovig (Biological) $15.12
- Victoza (Drug) $13.19
- JANUVIA (Drug) $12.01
- TOUJEO (Drug) $10.79
- INVOKANA (Drug) $10.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Lawrence
Lee Reussner, Md, MD
Specialist — Payments: $1,537
Dr. Warren Frick, M.d, M.D
Specialist — Payments: $1,511
Dr. Ronald Weiner, M.d, M.D
Specialist — Payments: $982.48
James Mandigo, M.d, M.D
Specialist — Payments: $467.53
Robert Dinsdale, Md, MD
Specialist — Payments: $464.73
Robert Knight, M.d, M.D
Specialist — Payments: $455.34